Routine governance filing with no new financial data or corporate events. Monitor next quarterly earnings for revenue and earnings trends.
TAK drugs
TAK drug pipeline →How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Jul 9 $16.61entry
- T+1 · 4mo ago −0.30%α −0.73% · $16.56
- T+5 · 4mo ago +0.72%α +0.85% · $16.73
- T+20 · 3mo ago +2.47%α +0.23% · $17.02
- T+60 · 7w ago +7.53%α +5.89% · $17.86
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Takeda filed its annual Corporate Governance Report, confirming compliance with all principles of the Corporate Governance Code. The report details board composition (8 of 11 directors are independent external directors, chair is independent), board effectiveness evaluation, and director compensation policy. No material financial or operational updates were disclosed.
Key Facts
- Company in full compliance with all Corporate Governance Code principles
- Board comprises 11 directors; 8 are independent external directors (majority); board chair is an independent external director
- No anti-takeover measures adopted; no parent company or major shareholder above 10%
- Board effectiveness evaluation concluded the BOD is operating effectively, noting a transition period with CEO succession and director offboarding
- Director compensation includes performance-based bonuses and long-term incentives (PSUs/RSUs) with clawback policy
Financial Impact
No financial figures reported
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001395064-26-000280 |
| Document: form6k_070926.htm | 0001395064-26-000280 |
| Document: 0001395064-26-000280-index-headers.html | 0001395064-26-000280 |
| Document: 0001395064-26-000280-index.html | 0001395064-26-000280 |
| Document: 0001395064-26-000280.txt | 0001395064-26-000280 |
Track record
18 reports on TAK
The track record builds as more bullish or bearish reports settle.
Filters
- Nov 5, 202611d ago Insider Cluster Neutral 2/10 Entry $21.19 to $21.12 Now $21.59 +1.89% ▼ −0.33% −3.62% vs SPY
- Oct 30, 202617d ago 144 Neutral 2/10 Entry $20.87 to $21.09 Now $21.59 +3.45% ▲ +1.05% +0.98% vs SPY
- Oct 30, 202617d ago 144 Neutral 2/10 Entry $20.87 to $21.09 Now $21.59 +3.45% ▲ +1.05% +0.98% vs SPY
- Oct 29, 202618d ago 6-K Neutral 4/10 No price data
- Oct 29, 202618d ago 6-K Bearish 5/10 Entry $20.01 to $21.19 Now $21.59 −7.90% ▼ −5.90% −10.62% vs SPY
- Sep 14, 20269w ago 6-K Bullish 7/10 Entry $18.60 to $18.89 Now $21.59 +16.08% ▲ +1.56% +1.45% vs SPY
- Aug 21, 202612w ago Insider Cluster Neutral 2/10 Entry $18.24 to $17.98 Now $21.59 +18.37% ▼ −1.43% −1.89% vs SPY
- Aug 19, 202612w ago Insider Cluster Neutral 2/10 Entry $18.13 to $18.03 Now $21.59 +19.08% ▼ −0.55% −1.67% vs SPY
- Aug 14, 202613w ago Court Ruling Neutral 4/10 Entry $17.38 to $18.24 Now $21.59 +24.22% ▲ +4.95% +6.14% vs SPY
- Aug 12, 202613w ago Insider Cluster Neutral 3/10 Entry $17.39 to $18.13 Now $21.59 +24.15% ▲ +4.26% +6.22% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers